T

Toshiyuki Shibata

Mie University

ORCID: 0000-0001-5639-8511

Publishes on Seaweed-derived Bioactive Compounds, Algal biology and biofuel production, Oral and Maxillofacial Pathology. 191 papers and 6.4k citations.

191Publications
6.4kTotal Citations

Is this you? Claim your profile.

Add your photo, update your bio, and get notified when your ranking changes.

Top publicationsby citations

Inhibitory activity of brown algal phlorotannins against hyaluronidase
Toshiyuki Shibata, Ken Fujimoto, Kohki Nagayama et al.|International Journal of Food Science & Technology|2002
Cited by 237

Abstract The inhibitory effect of brown algal phlorotannins on hyaluronidase was evaluated by an in vitro assay. Crude phlorotannins from the brown algae Eisenia bicyclis and Ecklonia kurome had a stronger inhibitory effect than well-known inhibitors such as catechins and sodium cromoglycate. IC50 values of the following six phlorotannins: phloroglucinol, an unknown tetramer, eckol (a trimer), phlorofucofuroeckol A (a pentamer), dieckol and 8,8′-bieckol (hexamers), were 280, 650, >800, 140, 120 and 40 μm, respectively. The IC50 of catechin, epigallocatechin gallate and sodium cromoglycate was 620, 190 and 270 μm, respectively. 8,8′-Bieckol, the strongest HAase inhibitor in this study, acted as a competitive inhibitor with an inhibition constant (Ki) of 35 μm. Acetylation of the phlorotannins markedly decreased their inhibitory potency.

Dental Pulp Cells for Induced Pluripotent Stem Cell Banking
Naritaka Tamaoki, Kazutoshi Takahashi, Takayuki Tanaka et al.|Journal of Dental Research|2010
Cited by 219

Defined sets of transcriptional factors can reprogram human somatic cells to induced pluripotent stem (iPS) cells. However, many types of human cells are not easily accessible to minimally invasive procedures. Here we evaluated dental pulp cells (DPCs) as an optimal source of iPS cells, since they are easily obtained from extracted teeth and can be expanded under simple culture conditions. From all 6 DPC lines tested with the conventional 3 or 4 reprogramming factors, iPS cells were effectively established from 5 DPC lines. Furthermore, determination of the HLA types of 107 DPC lines revealed 2 lines homozygous for all 3 HLA loci and showed that if an iPS bank is established from these initial pools, the bank will cover approximately 20% of the Japanese population with a perfect match. Analysis of these data demonstrates the promising potential of DPC collections as a source of iPS cell banks for use in regenerative medicine.